CERo Therapeutics Holdings, Inc. (CEROW)
NGM
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Peers in industry
CERo Therapeutics Holdings, Inc. has no peer companies in this window.
Recent press releases
CERo Therapeutics Holdings, Inc. has not issued a press release in this window.
SEC filings
All filings →CERo Therapeutics Holdings, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →CERo Therapeutics Holdings, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at CERo Therapeutics Holdings, Inc.
All people →No officers or directors have been indexed for CERo Therapeutics Holdings, Inc..